These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Enhanced repertoire of brain dynamical states during the psychedelic experience. Tagliazucchi E; Carhart-Harris R; Leech R; Nutt D; Chialvo DR Hum Brain Mapp; 2014 Nov; 35(11):5442-56. PubMed ID: 24989126 [TBL] [Abstract][Full Text] [Related]
5. Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis. Carhart-Harris RL; Leech R; Erritzoe D; Williams TM; Stone JM; Evans J; Sharp DJ; Feilding A; Wise RG; Nutt DJ Schizophr Bull; 2013 Nov; 39(6):1343-51. PubMed ID: 23044373 [TBL] [Abstract][Full Text] [Related]
6. Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals. McCulloch DE; Madsen MK; Stenbæk DS; Kristiansen S; Ozenne B; Jensen PS; Knudsen GM; Fisher PM J Psychopharmacol; 2022 Jan; 36(1):74-84. PubMed ID: 34189985 [TBL] [Abstract][Full Text] [Related]
7. Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention. Barrett FS; Krimmel SR; Griffiths RR; Seminowicz DA; Mathur BN Neuroimage; 2020 Sep; 218():116980. PubMed ID: 32454209 [TBL] [Abstract][Full Text] [Related]
8. Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin. Lebedev AV; Lövdén M; Rosenthal G; Feilding A; Nutt DJ; Carhart-Harris RL Hum Brain Mapp; 2015 Aug; 36(8):3137-53. PubMed ID: 26010878 [TBL] [Abstract][Full Text] [Related]
9. Psilocybin desynchronizes the human brain. Siegel JS; Subramanian S; Perry D; Kay BP; Gordon EM; Laumann TO; Reneau TR; Metcalf NV; Chacko RV; Gratton C; Horan C; Krimmel SR; Shimony JS; Schweiger JA; Wong DF; Bender DA; Scheidter KM; Whiting FI; Padawer-Curry JA; Shinohara RT; Chen Y; Moser J; Yacoub E; Nelson SM; Vizioli L; Fair DA; Lenze EJ; Carhart-Harris R; Raison CL; Raichle ME; Snyder AZ; Nicol GE; Dosenbach NUF Nature; 2024 Aug; 632(8023):131-138. PubMed ID: 39020167 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin's main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma. Kolaczynska KE; Liechti ME; Duthaler U J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1164():122486. PubMed ID: 33485158 [TBL] [Abstract][Full Text] [Related]
19. Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance. Dinis-Oliveira RJ Drug Metab Rev; 2017 Feb; 49(1):84-91. PubMed ID: 28074670 [TBL] [Abstract][Full Text] [Related]
20. Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain. Spain A; Howarth C; Khrapitchev AA; Sharp T; Sibson NR; Martin C Neuropharmacology; 2015 Dec; 99():210-20. PubMed ID: 26192543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]